Loading...
OTCM
CBNT
Market cap238kUSD
Nov 03, Last price  
0.00USD
Name

C-Bond Systems Inc

Chart & Performance

D1W1MN
OTCM:CBNT chart
P/E
0.13
P/S
0.10
EPS
0.00
Div Yield, %
Shrs. gr., 5y
105.72%
Rev. gr., 5y
45.45%
Revenues
2m
+11.46%
77,838124,637124,771105,00085,12377,69700723,612405,417382,244602,636658,4321,476,8282,232,6462,488,493
Net income
2m
P
-41,13314,55464,86038,89221,6136,052-52,820-63,376-52,859-57,018-9,904,719-7,240,740-4,434,443-7,144,383-5,117,9651,895,665
CFO
-2m
L+1.09%
-72,6758,71069,34444,9295,85431,801-39,466-48,880-47,510-54,909-1,967,782-1,313,711-1,783,027-1,807,051-1,584,918-1,602,218

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

C-Bond Systems, Inc., a nanotechnology enterprise founded in 2013 and based in Houston, Texas, concentrates on the ownership, development, production, and sale of its proprietary C-Bond technology across the United States. The company's innovative product line, rooted in C-Bond technology, includes: C-Bond NanoShield: A patented nanotechnology system designed to bolster windshield safety and performance through glass strengthening and the application of hydrophobic properties. C-Bond Secure: This patented, non-toxic, water-based nanotechnology solution enhances the durability of architectural glass and improves the functional characteristics of window film-to-glass integrations. C-Bond BRS: A patented nanotechnology ballistic-resistant film system that substantially increases the structural integrity of glass. Beyond its core C-Bond offerings, the company also distributes MB-10 and Vimoba disinfectant tablets. These products are supplied to a broad spectrum of clients and markets, encompassing educational institutions (schools and buses), automotive dealerships, global distribution networks, a variety of service providers, and sectors such as transportation detailing, automotive, trucking, RVs, rental agencies, service vehicles, mass transit, golf carts, aviation, trains, and marine operations.
IPO date
Jun 16, 2009
Employees
17
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT